Further, in Vldlr-/- retinas, NADH oxidation was similarly decreased, and restored by systemic treatment with PPARα agonist fenofibric acid (Fig. 5f), suggesting that PPARα activation increased retinal energy efficiency in an AMD-like model. The gene discussed is VLDLR; the disease is age-related macular degeneration.